Anticholinergic (Muscarinic Antagonist) — Perioperative
Pregnancy: Used intraoperatively — crosses placenta minimally
Glycopyrronium (Perioperative — Anticholinergic)
Brand names: Robinul
Adult dose
Dose: With neostigmine (reversal): 200–400 mcg IV with each 2.5 mg neostigmine IV (ratio 1:5 glycopyrronium:neostigmine by weight). Antisialagogue (pre-op secretions): 200 mcg IV/IM. Bradycardia: 200–400 mcg IV
Route: IV or IM
Frequency: Single dose (reversal/pre-op); repeat if needed (bradycardia)
Max: 400 mcg per dose; titrate to HR
Does NOT cross blood-brain barrier (quaternary ammonium compound) — no CNS effects. Preferred over atropine as reversal adjunct — smoother HR control. Duration of antisialagogue effect 4–8h. Can be mixed with neostigmine in same syringe.
Paediatric dose
Dose: 0.01 mg/kg
Route: IV
Frequency: Single dose with neostigmine
Max: 0.2 mg per dose
Concentration: 200 mcg/mL mg/ml
Children: 0.01 mg/kg IV with neostigmine. Neonates: 0.01 mg/kg IV with neostigmine 0.05 mg/kg — always co-administer.
Dose adjustments
Renal
No dose adjustment required
Hepatic
No dose adjustment required
Paediatric weight-based calculator
Children: 0.01 mg/kg IV with neostigmine. Neonates: 0.01 mg/kg IV with neostigmine 0.05 mg/kg — always co-administer.
Clinical pearls
- No CNS penetration: unlike atropine, glycopyrronium does not cross the blood-brain barrier — no central anticholinergic effects (agitation, delirium)
- Preferred over atropine for neostigmine reversal co-administration: duration better matched to neostigmine (both 30–60 min)
- Antisialagogue: given pre-operatively for procedures with high secretion risk (airway surgery, bronchoscopy, paediatric intubation)
- Bronchial smooth muscle relaxation: reduces respiratory secretions intraoperatively
- Robinul-Neostigmine combined preparation: available as pre-mixed syringe in some formularies
Contraindications
- Glaucoma (angle-closure)
- Pyloric stenosis
- Paralytic ileus
- Urinary retention (BPH)
Side effects
- Tachycardia
- Dry mouth
- Urinary retention
- Constipation
- Blurred vision
- No CNS side effects (unlike atropine — does not cross BBB)
Interactions
- Neostigmine — always co-administered to counteract muscarinic effects of reversal
- Other anticholinergics — additive effects
Monitoring
- Heart rate (tachycardia)
- Urinary output (urinary retention risk)
- Secretion control (antisialagogue effect)
Reference: BNFc; BNF; AAGBI Reversal of Neuromuscular Block Guidelines; RCoA Anaesthetic Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- ASA Physical Status Classification · Pre-operative Risk
- POSSUM Score for Surgical Morbidity and Mortality · Perioperative Risk
- SORT (Surgical Outcome Risk Tool) · Perioperative Risk
- Revised Cardiac Risk Index (RCRI / Lee Index) · Perioperative Risk
- ASA Physical Status Classification · Perioperative Risk
- Revised Cardiac Risk Index (RCRI) · Pre-operative Risk
Pathways
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Faecal Peritonitis · ASGBI; RCS — Best Practice
- Acute Compartment Syndrome · BAPRAS; BOA; RCS — Best Practice